Shankar Siva
Peter MacCallum Cancer Centre, Australia
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Shankar Siva as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:05 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT07135882 · Primary Radiotherapy In MEtastatic Lung CancerTrans Tasman Radiation Oncology Group · recruiting · Carcinoma, Non-Small-Cell Lung (NSCLC) · study chair
- Ph2NCT05560659 · Lu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative RadiotherapyPeter MacCallum Cancer Centre, Australia · recruiting · Oligometastatic Prostate Cancer · principal investigator
- Ph1NCT05222087 · PRIME_LUNG: Primary Radiotherapy In MEtastatic Lung Cancer - A Pilot StudyPeter MacCallum Cancer Centre, Australia · unknown · NSCLC · principal investigator
- Ph2NCT05024318 · NeoAdjuvant Pembrolizumab and STEreotactic Radiotherapy Prior to Nephrectomy for Renal Cell CarcinomaPeter MacCallum Cancer Centre, Australia · unknown · Renal Cell Carcinoma, Clear Cell, Somatic · study chair
- Ph2NCT04319783 · Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMATrans Tasman Radiation Oncology Group · active not recruiting · Advanced Prostate Carcinoma, Cancer of Prostate, PSA · study chair
- Ph1/Ph2NCT02855203 · Stereotactic Radiotherapy and Anti-PD1 Antibody (Pembrolizumab) for Oligometastatic Renal TumoursPeter MacCallum Cancer Centre, Australia · completed · Renal Cell Carcinoma · study chair
- Ph2NCT02613819 · Focal Ablative STereotactic Radiosurgery for Cancers of the KidneyTrans Tasman Radiation Oncology Group · completed · Renal Cell Carcinoma · principal investigator
- N/ANCT01965223 · A Randomized Phase II Study of Stereotactic Ablative Body Radiotherapy for Metastases to the Lung (TROG 13.01 SAFRON II)Trans Tasman Radiation Oncology Group · completed · Cancer, Metastases to the Lung · study chair
- N/ANCT01676428 · A Pilot Study of Focal Ablative STereotactic RAdiosurgery for Cancers of the Kidney or Isolated Adrenal MetastasesPeter MacCallum Cancer Centre, Australia · completed · Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:05 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in non-small cell lung cancer, ranked by citations from NIH iCite, fetched 2026-11-12 11:05 UTC. The ranking covers the 200 most relevant of 13 PubMed records, and a shared surname and initials can bring in a namesake. All 13 on PubMed
- 93 citationsRCR 3.0
- High-resolution pulmonary ventilation and perfusion PET/CT allows for functionally adapted intensity modulated radiotherapy in lung cancer.Radiother Oncol · 201589 citationsRCR 4.3
- Systematic endoscopic staging of mediastinum to guide radiotherapy planning in patients with locally advanced non-small-cell lung cancer (SEISMIC): an international, multicentre, single-arm, clinical trial.Lancet Respir Med · 202466 citationsRCR 9.3
- Radiotherapy for Non-Small Cell Lung Cancer Induces DNA Damage Response in Both Irradiated and Out-of-field Normal Tissues.Clin Cancer Res · 201660 citationsRCR 2.3
- 23 citationsRCR 1.0
- Safety and Efficacy Results From iSABR, a Phase 1 Study of Stereotactic ABlative Radiotherapy in Combination With Durvalumab for Early-Stage Medically Inoperable Non-Small Cell Lung Cancer.Int J Radiat Oncol Biol Phys · 202322 citationsRCR 1.7
- 19 citationsRCR 1.2
- Single-Fraction Stereotactic Ablative Body Radiotherapy to the Lung - The Knockout Punch.Clin Oncol (R Coll Radiol) · 202215 citationsRCR 1.3
- The HI-FIVE Trial: A Prospective Trial Using 4-Dimensional 68Ga Ventilation-Perfusion Positron Emission Tomography-Computed Tomography for Functional Lung Avoidance in Locally Advanced Non-small Cell Lung Cancer.Int J Radiat Oncol Biol Phys · 202312 citationsRCR 1.9
- Comparison of Changes in Pulmonary Function After Stereotactic Body Radiation Therapy Versus Conventional 3-Dimensional Conformal Radiation Therapy for Stage I and IIA Non-Small Cell Lung Cancer: An Analysis of the TROG 09.02 (CHISEL) Phase 3 Trial.Int J Radiat Oncol Biol Phys · 20235 citationsRCR 0.6